HONG KONG, Oct 9 (Reuters Breakingviews) - Artificial intelligence will transform industries and economies. Yet while fears are growing in the United States that spending on advanced chips and data ...

Investor T. Rowe opposes the software firm’s $12 bln sale to Thoma Bravo. Buyout barons are eyeing valuations tanked by high rates and machine learning anxiety. Yet the offer matches the value of ...

Brussels committed 1 bln euros to boost artificial intelligence. It won’t bridge the investment gap with the US or make up for the lack of a leading EU chip designer. But focusing on industrial ...

Masayoshi Son is buying ABB’s industrial robotics unit for $5 bln. It's profitable, yet SoftBank is paying up for a business that seems strategically unexciting. Still, Son's capacity for inspired ...

Banks like Lloyds may pay $15 bln for not properly disclosing commissions on car loans. That's lower than feared. But it highlights how the UK financial sector is prone to poor oversight followed by ...

Investors may need to tap the brakes on MG-owner SAIC Motor . The $28 billion state-backed Chinese carmaker sports a racy valuation. Yet margins are low, new rivals proliferate, and its overseas ...

A market rally has seen the implied return that shareholders require of JPMorgan and others fall well below a 10% rule of thumb. Such a low cost of equity suggests utility-like solidity. High capital ...

Investors are shrugging off reports that Beijing has banned the $153 bln miner's iron ore amid price talks. But China's purchases account for more than 50% of EBITDA at BHP and Rio Tinto. Acquisitions ...

ICE will invest up to $2 bln in the predictions venue beloved by sports and politics punters. It follows rival CME’s tie-up with FanDuel. Both deals tap into easing regulations and amateur traders’ ...

Verisure, a security firm, plans to float in Stockholm with a valuation of $22 bln including debt. Sticky revenue and market optimism are enabling it to price at only a modest discount to peers. The ...

AstraZeneca’s New York pivot contains a booby prize for the UK government. Last week, the $264 billion Anglo-Swedish pharma giant announced a plan to list its shares directly in the U.S. While the ...

A $600 bln rise in assets juggled by traders at big US banks came with little reported risk. It makes sense: as hedge funds and private credit grew, the likes of JPMorgan shifted to financing them. It ...